CN1198621C - 含有雌二醇的贴剂 - Google Patents

含有雌二醇的贴剂 Download PDF

Info

Publication number
CN1198621C
CN1198621C CNB018190901A CN01819090A CN1198621C CN 1198621 C CN1198621 C CN 1198621C CN B018190901 A CNB018190901 A CN B018190901A CN 01819090 A CN01819090 A CN 01819090A CN 1198621 C CN1198621 C CN 1198621C
Authority
CN
China
Prior art keywords
estradiol
patch
absorption enhancer
adhesive phase
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018190901A
Other languages
English (en)
Chinese (zh)
Other versions
CN1474695A (zh
Inventor
丸尾享
早稻田裕之
花岛伸明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of CN1474695A publication Critical patent/CN1474695A/zh
Application granted granted Critical
Publication of CN1198621C publication Critical patent/CN1198621C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
CNB018190901A 2000-11-17 2001-11-13 含有雌二醇的贴剂 Expired - Fee Related CN1198621C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000350657 2000-11-17
JP350657/2000 2000-11-17

Publications (2)

Publication Number Publication Date
CN1474695A CN1474695A (zh) 2004-02-11
CN1198621C true CN1198621C (zh) 2005-04-27

Family

ID=18823846

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018190901A Expired - Fee Related CN1198621C (zh) 2000-11-17 2001-11-13 含有雌二醇的贴剂

Country Status (5)

Country Link
JP (1) JP3935839B2 (ja)
KR (1) KR100533493B1 (ja)
CN (1) CN1198621C (ja)
AU (1) AU2002212763A1 (ja)
WO (1) WO2002040031A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258724A1 (en) * 2003-01-03 2004-12-23 Dpc Products, Inc. Gilsonite derived pharmaceutical delivery compositions and methods
JP7112256B2 (ja) * 2018-06-08 2022-08-03 株式会社日本触媒 粘着剤組成物及びその利用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0344326A (ja) * 1989-07-10 1991-02-26 Sekisui Chem Co Ltd 経皮吸収製剤
JP2507068B2 (ja) * 1989-07-10 1996-06-12 積水化学工業株式会社 経皮吸収製剤
JP2718433B2 (ja) * 1989-09-08 1998-02-25 シグナス インコーポレイテッド 経皮ドラッグデリバリーのための固体マトリックスシステム
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern

Also Published As

Publication number Publication date
KR20040011430A (ko) 2004-02-05
JPWO2002040031A1 (ja) 2004-03-18
JP3935839B2 (ja) 2007-06-27
AU2002212763A1 (en) 2002-05-27
KR100533493B1 (ko) 2005-12-06
CN1474695A (zh) 2004-02-11
WO2002040031A1 (fr) 2002-05-23

Similar Documents

Publication Publication Date Title
EP0186019B1 (de) Wirkstoffpflaster
KR100693824B1 (ko) 중화된 아크릴산 접착 패치를 갖는 경피성 치료 시스템
CA2033113C (en) Estrogen-containing gel preparation
KR970007900B1 (ko) 경피 약제
KR100561255B1 (ko) 호르몬 방출용 트랜스더멀 치료 시스템
JPH07258060A (ja) 皮膚美白用貼付剤
DE4241874A1 (de) Medizinisches Pflaster für die perkutane Verabreichung
AU782249B2 (en) Patches containing buprenorphine hydrochloride
AU2012332254A1 (en) Dermal delivery compositions and methods
KR0163597B1 (ko) 니트로글리세린의 경피 투여형 약제
EP1385490B1 (de) Haftkleber auf basis von ethylen-vinylacetat-copolymeren und klebharzen, für medizinische verwendungszwecke
EP0773028A1 (en) Percutaneously absorbable preparation
CN1198621C (zh) 含有雌二醇的贴剂
MXPA02001152A (es) Suministro transdermico lasofoxifeno.
CN112826809B (zh) 一种稳定的妥洛特罗经皮吸收制剂
CN1187042C (zh) 含甾族化合物的硬膏剂,其制备方法及其应用
WO2001049273A2 (de) Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff
JP3792305B2 (ja) 医療用粘着性組成物
AU2011324394B2 (en) Felbinac-containing external patch
DE19828274C2 (de) Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
JPH10316825A (ja) 粘着性組成物
JP2839635B2 (ja) エストラジオール含有貼付剤
JPH09309824A (ja) 粘着剤組成物及びそれを用いた貼付剤
WO2000001374A1 (de) Therapeutisches system mit zusatz von perlglanzpigmenten

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050427

Termination date: 20131113